Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775656 · ClinicalTrials.gov registry record
UCB Cimzia Pregnancy Follow-up Study
A clinical trial, sponsored by UCB Biosciences.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02775656 is a clinical trial that was terminated before completion, run by UCB Biosciences. The registered enrollment target is 1 participants.
The verdict
NCT02775656 was terminated before completion, sponsored by UCB Biosciences.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02775656
The ClinicalTrials.gov registry entry for NCT02775656 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCB Biosciences, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02775656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02775656 about?
NCT02775656 is a clinical study titled "UCB Cimzia Pregnancy Follow-up Study". The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnanc...
What is the current status of trial NCT02775656?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2016-11. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02775656?
This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.